Genitourinary syndrome of menopause and age: a new algorithm for hormonal treatment?
- PMID: 33350673
- DOI: 10.1097/GME.0000000000001714
Genitourinary syndrome of menopause and age: a new algorithm for hormonal treatment?
Conflict of interest statement
Financial disclosure/conflicts of interest: None reported.
Comment on
-
Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets.Menopause. 2020 Oct 5;28(2):113-118. doi: 10.1097/GME.0000000000001666. Menopause. 2020. PMID: 33038141 Clinical Trial.
References
-
- Derzko CM, Röhrich S, Panay N. Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets. Menopause 2021; 28:113–118.
-
- Portman DJ, Glass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Health and The North American Menopause Society. Menopause 2014; 21:1063–1068.
-
- Nappi RE, Kokot-Kierepa M. Women's voices in the menopause: results from an international survey on vaginal atrophy. Maturitas 2010; 67:233–238.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
